Noom has launched a new Proactive Health GLP-1 Program focused on preventive health care. The program includes at-home testing of 17 biomarkers, behavioral support, and personalized GLP-1 microdosing ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. January has a funny way of making us ambitious.

The Trump administration announced a new demonstration program aimed at easing access to GLP-1 receptor agonists for enrollees in Medicare Part D and Medicaid plans, but experts say it's unclear how ...

Summer Kessel is a Registered Dietitian and Certified Specialist in Obesity and Weight Management. She is currently serving as cofounder and chief of operations, Community & Nutrition at Vineyard, a ...

Add Yahoo as a preferred source to see more of our stories on Google. Having an oral version of the medication, which had only been available as an injectable until now, is a “very big deal,” says ...

American patients can now receive the first-ever GLP-1 pill for weight loss from Novo Nordisk, marking a new chapter of obesity treatment in the U.S. The cash prices for the drug, called the Wegovy ...

Data: N.C. Department of Health and Human Services; Chart: Axios Visuals North Carolina is one of 13 states whose Medicaid programs cover GLP-1s for weight loss treatment, and their usage in the state ...

The FDA requested that manufacturers of GLP-1 receptor agonists remove information regarding risks of suicidal behavior and ideation from drug labels following a detailed review of existing data, the ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

GLP-1 weight-loss pills appear to be just as effective as injections, with clinical trials showing similar average weight loss when taken correctly. The safety profile of GLP-1 pills largely mirrors ...

As the number of consumers using weight loss drugs grows — with 23% of U.S. households reporting someone on GLP-1 medications, according to Circana data from September 2025 — the foodservice industry ...

Everything from AI-generated videos of celebrities to fake online pharmacies are being used to try to dupe consumers searching for weight-loss drugs. As the popularity of weight-loss drugs continues ...